Telix Pharmaceuticals Ltd
TLPPF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002007191
In the last 90 days, Telix Pharmaceuticals Ltd insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesTLX
Key figures
- Insider buysLast 90 days, $20.0K in total
- 1
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding TLPPF, Q2 2026
No superinvestor reported holding TLPPF at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Telix Pharmaceuticals Ltd insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 (view filing)7:20 PM ET | Sep 7 | 7 daysLate | Smith Darren CharltonGroup Chief Financial Officer | PPurchase | +2.07K | $9.66 | +$20.0K | +17.4%14.0K after | |
| May 6, 2026 (view filing) | Apr 28-29 | 8 daysLate | Behrenbruch ChristianMD & Group CEO | PPurchase | +67.9K | $14.67 | +$996.7K | +0.3%20.7M after | 2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Telix Pharmaceuticals Ltd at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding TLPPF in 13F filings for Q2 2026.